Susquehanna International Group, LLP Rhythm Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 24,125 shares of RYTM stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,125

Previous 103,253 76.64%

Holding current value

$1.24 Million

Previous $4.47 Million 77.87%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$35.41 - $44.37 $2.8 Million - $3.51 Million	-79,128 Reduced 76.64%	24,125 $990,000
Q1 2024 May 07, 2024	BUY	$39.12 - $52.44 $2.78 Million - $3.72 Million	71,021 Added 220.34%	103,253 $4.47 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $37,988 - $88,160	1,776 Added 5.83%	32,232 $1.48 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $223,837 - $393,592	14,158 Added 86.87%	30,456 $698,000
Q2 2023 Aug 11, 2023	SELL	$16.32 - $21.15 $12.5 Million - $16.2 Million	-768,257 Reduced 97.92%	16,298 $268,000
Q1 2023 May 16, 2023	BUY	$16.88 - $34.24 $1.53 Million - $3.1 Million	90,513 Added 13.04%	784,555 $14 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $30.25 $10.7 Million - $14.5 Million	479,520 Added 223.53%	694,042 $20.2 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $646,122 - $4.64 Million	150,261 Added 233.83%	214,522 $5.26 Million
Q2 2022 Aug 15, 2022	BUY	$3.12 - $12.25 $145,360 - $570,727	46,590 Added 263.65%	64,261 $267,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $286,865 - $572,795	-46,797 Reduced 72.59%	17,671 $204,000
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $97,104 - $156,583	11,265 Added 21.17%	64,468 $643,000
Q3 2021 Nov 15, 2021	BUY	$11.68 - $20.72 $112,922 - $200,320	9,668 Added 22.21%	53,203 $695,000
Q2 2021 Aug 11, 2021	SELL	$18.52 - $22.55 $1.49 Million - $1.81 Million	-80,202 Reduced 64.82%	43,535 $852,000
Q1 2021 May 17, 2021	BUY	$20.25 - $39.49 $1.46 Million - $2.85 Million	72,222 Added 140.2%	123,737 $2.63 Million
Q4 2020 Feb 16, 2021	SELL	$21.17 - $32.61 $375,788 - $578,860	-17,751 Reduced 25.63%	51,515 $1.53 Million
Q3 2020 Nov 16, 2020	BUY	$18.13 - $30.61 $1.08 Million - $1.82 Million	59,391 Added 601.43%	69,266 $1.5 Million
Q2 2020 Aug 14, 2020	SELL	$14.41 - $25.35 $84,010 - $147,790	-5,830 Reduced 37.12%	9,875 $220,000
Q1 2020 May 15, 2020	BUY	$13.16 - $22.9 $206,677 - $359,644	15,705 New	15,705 $239,000
Q4 2019 Feb 14, 2020	SELL	$19.53 - $25.5 $230,102 - $300,441	-11,782 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$18.62 - $24.51 $58,615 - $77,157	-3,148 Reduced 21.09%	11,782 $254,000
Q2 2019 Aug 16, 2019	BUY	$21.11 - $28.48 $315,172 - $425,206	14,930 New	14,930 $328,000

Others Institutions Holding RYTM

# of Institutions

178

Shares Held

69.1M

Call Options Held

467K

Put Options Held

224K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Rhythm Pharmaceuticals, Inc. Transaction History